Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vachon

Showing results (291-300 of 408) with videos related to

Pageof 41
Sort By:
American Journal of Hematology|April 13, 2020
Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic indexGeffen Kleinstern, Daniel R O'Brien, Xing Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Genetic susceptibility variants for chronic lymphocytic leukemiaSusan L Slager, Lynn R Goldin, Sara S Strom, et al.
JNCI Cancer Spectrum|January 9, 2025
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013Amy C Degnim, Karthik Ghosh, Robert A Vierkant, et al.
Blood Cancer Journal|November 6, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh, et al.
Blood Cancer Journal|April 14, 2022
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6Alyssa Clay-Gilmour, Subhayan Chattopadhyay, Michelle A T Hildebrandt, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2026
Establishment of harmonized international reference ranges for plasma estradiol concentrations in postmenopausal womenJinghan Cui, Susan E Hankinson, Alvin M Matsumoto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 12, 2013
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypesSusan L Slager, Sara J Achenbach, Yan W Asmann, et al.
Plos Genetics|February 2, 2018
Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma riskRosalie G Waller, Todd M Darlington, Xiaomu Wei, et al.
Blood Cancer Journal|November 11, 2024
Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcomeMatteo Giaccherini, Alyssa I Clay-Gilmour, Romano Liotti, et al.
Blood Cancer Journal|August 7, 2019
Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosisAlyssa I Clay-Gilmour, Abdul R Rishi, Lynn R Goldin, et al.
Pageof 41

Showing results (291-300 of 408) with videos related to

Sort By:
Pageof 41
American Journal of Hematology|April 13, 2020
Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic indexGeffen Kleinstern, Daniel R O'Brien, Xing Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Genetic susceptibility variants for chronic lymphocytic leukemiaSusan L Slager, Lynn R Goldin, Sara S Strom, et al.
JNCI Cancer Spectrum|January 9, 2025
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013Amy C Degnim, Karthik Ghosh, Robert A Vierkant, et al.
Blood Cancer Journal|November 6, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh, et al.
Blood Cancer Journal|April 14, 2022
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6Alyssa Clay-Gilmour, Subhayan Chattopadhyay, Michelle A T Hildebrandt, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2026
Establishment of harmonized international reference ranges for plasma estradiol concentrations in postmenopausal womenJinghan Cui, Susan E Hankinson, Alvin M Matsumoto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 12, 2013
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypesSusan L Slager, Sara J Achenbach, Yan W Asmann, et al.
Plos Genetics|February 2, 2018
Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma riskRosalie G Waller, Todd M Darlington, Xiaomu Wei, et al.
Blood Cancer Journal|November 11, 2024
Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcomeMatteo Giaccherini, Alyssa I Clay-Gilmour, Romano Liotti, et al.
Blood Cancer Journal|August 7, 2019
Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosisAlyssa I Clay-Gilmour, Abdul R Rishi, Lynn R Goldin, et al.
Pageof 41